Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

CB2 (non-phospho) Cannabinoid Receptor 2 Antibody

NEW
$ 400.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

  • 7TM0057N
  • 100 µl
  • Rabbit
The non-phospho-CB2 receptor antibody is directed against the distal end of the... more

The non-phospho-CB2 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human CB2. It can be used to detect total CB2 receptors in Western blots independent of phosphorylation. The CB2 antibody can also be used to isolate and enrich CB2 receptors from tissue lysates. It also detects CB2 in cultured cells and tissue sections by immunohistochemistry.

  Alternative Names CB2-R, Peripheral Cannabinoid Receptor IUPHAR... more

 

Alternative Names CB2-R, Peripheral Cannabinoid Receptor
IUPHAR Target ID  57
UniProt ID  P34927
Western Blot (WB)  1:1000
Species Reactivity   Human
Host / Isotype Rabbit / IgG
Class Polyclonal
Immunogen A synthetic peptide presents the carboxyl-terminal tail of human CB2.
Form  Liquid
Purification Antigen affinity chromatography
Storage buffer Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide
Storage conditions short-term 4°C, long-term -20°C
Figure 1. Validation of the Cannabinoid Receptor 2... more

Figure 1. Validation of the Cannabinoid Receptor 2 in transfected HEK293 cells. Native HEK293 cells (MOCK) or HEK293 cells stably expressing the Cannabinoid Receptor 2 (CB2) were lysed and immunoblotted with the anti-CB2 antibody (7TM0057N) at a dilution of 1:1000.

Figure 2. Immunohistochemical identification of the Cannabinoid Receptor 2 in kidney. Sections were dewaxed, microwaved in citric acid, and incubated with anti-CB2 (Cannabinoid Receptor 2) antibody (7TM0057N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution.Color was developed by incubation in 3-amino-9-ethylcarbazole (AEC), and sections were counterstained with hematoxylin.

 

Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and... more

Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Commun Biol. 2023 Apr 15;6(1):419. doi: 10.1038/s42003-023-04786-2. PMID: 37061609; PMCID: PMC10105690.

Read, write and discuss reviews... more
Customer evaluation for "CB2 (non-phospho) Cannabinoid Receptor 2 Antibody"
Write an evaluation
Evaluations will be activated after verification.

The fields marked with * are required.

Recently viewed